These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 25655342

  • 1. 18F-FDG PET/CT Findings in Portal Vein Thrombosis and Liver Metastases.
    Surasi DS, O'Malley JP, Bhambhvani P.
    J Nucl Med Technol; 2015 Sep; 43(3):229-30. PubMed ID: 25655342
    [Abstract] [Full Text] [Related]

  • 2. The role of 18F-FDG PET/CT in differentiating malignant from benign portal vein thrombosis.
    Hu S, Zhang J, Cheng C, Liu Q, Sun G, Zuo C.
    Abdom Imaging; 2014 Dec; 39(6):1221-7. PubMed ID: 24913670
    [Abstract] [Full Text] [Related]

  • 3. The impact of 18F-FDG PET/CT in patients with liver metastases.
    Chua SC, Groves AM, Kayani I, Menezes L, Gacinovic S, Du Y, Bomanji JB, Ell PJ.
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):1906-14. PubMed ID: 17713766
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited.
    Zhang X, Wu F, Han P.
    Hell J Nucl Med; 2014 Dec; 17(3):177-83. PubMed ID: 25526754
    [Abstract] [Full Text] [Related]

  • 9. [Dual-time point images of the liver with (18)F-FDG PET/CT in suspected recurrence from colorectal cancer].
    Fuster D, Lafuente S, Setoain X, Navales I, Perissinotti A, Pavia J, Paredes P, Lomeña F, Pons F.
    Rev Esp Med Nucl Imagen Mol; 2012 Dec; 31(3):111-6. PubMed ID: 22154291
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Detection of residual tumor following radiofrequency ablation of liver metastases using 18F-FDG PET/PET-CT: a systematic review and meta-analysis.
    Zheng JH, Chang ZH, Han CB, Ma JT, Liu ZY, Lu ZM, Guo QY.
    Nucl Med Commun; 2014 Apr; 35(4):339-46. PubMed ID: 24323312
    [Abstract] [Full Text] [Related]

  • 12. Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases.
    D'souza MM, Sharma R, Mondal A, Jaimini A, Tripathi M, Saw SK, Singh D, Mishra A, Tripathi RP.
    Nucl Med Commun; 2009 Feb; 30(2):117-25. PubMed ID: 19057427
    [Abstract] [Full Text] [Related]

  • 13. 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.
    Zhou M, Wang C, Hu S, Zhang Y, Yao Z, Li J, Guo W, Zhang Y.
    Nucl Med Commun; 2013 Jul; 34(7):694-700. PubMed ID: 23604223
    [Abstract] [Full Text] [Related]

  • 14. The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging.
    Mittal BR, Manohar K, Kashyap R, Bhattacharya A, Singh B, Singh G.
    Hell J Nucl Med; 2011 Jul; 14(2):135-9. PubMed ID: 21761015
    [Abstract] [Full Text] [Related]

  • 15. Impact of Fluorodeoxyglucose PET/Computed Tomography on the Management of Patients with Colorectal Cancer.
    Laurens ST, Oyen WJ.
    PET Clin; 2015 Jul; 10(3):345-60. PubMed ID: 26099671
    [Abstract] [Full Text] [Related]

  • 16. Positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma.
    Sun L, Wu H, Pan WM, Guan YS.
    World J Gastroenterol; 2007 Sep 07; 13(33):4529-32. PubMed ID: 17724816
    [Abstract] [Full Text] [Related]

  • 17. Response assessment of colorectal liver metastases with contrast enhanced CT/18F-FDG PET.
    García Vicente AM, Domínguez Ferreras E, Sánchez Pérez V, Poblete García VM, Villa Guzmán JC, Jiménez Aragón F, Pineda Pineda MD, Molino Trinidad C, Soriano Castrejón Á.
    Eur J Radiol; 2013 Jun 07; 82(6):e255-61. PubMed ID: 23414715
    [Abstract] [Full Text] [Related]

  • 18. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
    Husby JA, Reitan BC, Biermann M, Trovik J, Bjørge L, Magnussen IJ, Salvesen ØO, Salvesen HB, Haldorsen IS.
    J Nucl Med; 2015 Aug 07; 56(8):1191-8. PubMed ID: 26045311
    [Abstract] [Full Text] [Related]

  • 19. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography and magnetic resonance imaging in patients with liver metastases from uveal melanoma: results from a pilot study.
    Orcurto V, Denys A, Voelter V, Schalenbourg A, Schnyder P, Zografos L, Leyvraz S, Delaloye AB, Prior JO.
    Melanoma Res; 2012 Feb 07; 22(1):63-9. PubMed ID: 22027909
    [Abstract] [Full Text] [Related]

  • 20. Comparison of positron emission tomography and bremsstrahlung imaging to detect particle distribution in patients undergoing yttrium-90 radioembolization for large hepatocellular carcinomas or associated portal vein thrombosis.
    Padia SA, Alessio A, Kwan SW, Lewis DH, Vaidya S, Minoshima S.
    J Vasc Interv Radiol; 2013 Aug 07; 24(8):1147-53. PubMed ID: 23792126
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.